¼¼°èÀÇ Ç÷°ü³» µ¿¸Æ·ù ¼öº¹¼ú ½ÃÀå
Endovascular Aneurysm Repair
»óǰÄÚµå : 1757713
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 276 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,053,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,161,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Ç÷°ü³» µ¿¸Æ·ù ¼öº¹¼ú ¼¼°è ½ÃÀåÀº 2030³â±îÁö 30¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 25¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â Ç÷°ü³» µ¿¸Æ·ù ¼öº¹¼ú ¼¼°è ½ÃÀåÀº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 3.3%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 30¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ º¹ºÎ ´ëµ¿¸Æ·ù´Â CAGR 3.0%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 16¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÈäºÎ ´ëµ¿¸Æ·ù ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ CAGR·Î 3.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 7,760¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 6.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Ç÷°ü³» µ¿¸Æ·ù ¼öº¹¼ú ½ÃÀåÀº 2024³â¿¡ 6¾ï 7,760¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 5¾ï 9,680¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 6.1%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.3%¿Í 2.5%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Ç÷°ü³» µ¿¸Æ·ù ¼öº¹¼ú ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Ç÷°ü³» µ¿¸Æ·ù ¼öº¹¼úÀÌ Ç÷°ü ÀÇ·á¿¡¼­ µ¿¸Æ·ù Ä¡·á¸¦ ÀçÁ¤ÀÇÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

Ç÷°ü³» µ¿¸Æ·ù ¼öº¹¼ú(EVAR)Àº ±âÁ¸ÀÇ °³º¹ ¼ö¼úÀ» ´ëüÇÒ ¼ö ÀÖ´Â ÃÖ¼Òħ½ÀÀû Ä¡·á¹ýÀ» Á¦°øÇÔÀ¸·Î½á º¹ºÎ ¹× ÈäºÎ ´ëµ¿¸Æ·ù °ü¸®¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ÀÌ ½Ã¼úÀº »çŸ±¸´ÏÀÇ ÀÛÀº Àý°³Ã¢À» ÅëÇØ ½ºÅÙÆ® ÀÌ½ÄÆíÀ» »ðÀÔÇÏ¿© ´ëÅ𵿸ÆÀ» ÅëÇØ µ¿¸Æ·ù ºÎÀ§±îÁö À̵¿½ÃŲ ÈÄ, ±×°÷¿¡¼­ ½ºÅÙÆ® ÀÌ½ÄÆíÀ» Àü°³ÇÏ¿© ¾àÇØÁø Ç÷°üº®À» º¸°­ÇÏ°í ÆÄ¿­À» ¹æÁöÇÏ´Â ¹æ½ÄÀ¸·Î, °³º¹¼ö¼ú¿¡ ºñÇØ ÃâÇ÷·® °¨¼Ò, ¼ö¼ú ÀüÈÄ ÀÌȯÀ² °¨¼Ò, ÀÔ¿ø±â°£ ´ÜÃà, ȸº¹½Ã°£ ´ÜÃà µî ¸¹Àº ÀÌÁ¡ÀÌ ÀÖ½À´Ï´Ù. ȸº¹½Ã°£ ´ÜÃà µî ¸¹Àº ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ƯÈ÷ °í·ÉÀÇ È¯ÀÚ³ª ÇÕº´ÁõÀÌ ÀÖ¾î ´ë¼ö¼úÀ» °ßµô ¼ö ¾ø´Â ȯÀÚ¿¡°Ô À¯¸®ÇÕ´Ï´Ù. Àα¸ °í·ÉÈ­, °íÇ÷¾Ð, Èí¿¬, µ¿¸Æ°æÈ­Áõ µîÀ¸·Î ÀÎÇÑ ´ëµ¿¸Æ·ù ¹ß»ý·üÀÌ Àü ¼¼°èÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó EVAR°ú °°Àº º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀÎ ÁßÀç½Ã¼ú¿¡ ´ëÇÑ ÀÓ»óÀû ¿ä±¸°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Ç÷°ü ¿µ»ó°ú ½ºÅÙÆ® ±×·¡ÇÁÆ®ÀÇ µðÀÚÀÎÀÌ Áö¼ÓÀûÀ¸·Î °³¼±µÊ¿¡ µû¶ó, EVARÀº ÀûÀýÇÑ ÇØºÎÇÐÀû ±¸Á¶¸¦ °¡Áø ¸¹Àº ȯÀڵ鿡°Ô ù ¹øÂ° ¼±Åà ġ·á¹ýÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ºÅ©¸®´× ÇÁ·Î±×·¥ÀÇ º¸±Þ°ú ¿µ»ó Áø´ÜÀÇ °³¼±À¸·Î ¹«Áõ»ó µ¿¸Æ·ùÀÇ Á¶±â ¹ß°ßÀÌ °¡´ÉÇØÁü¿¡ µû¶ó EVARÀÇ ÀáÀçÀû Ä¡·á ´ë»óÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ±× °á°ú, EVARÀº µ¿¸Æ·ù Ä¡·á ¹æ¹ýÀ» º¯È­½ÃÄ×À» »Ó¸¸ ¾Æ´Ï¶ó, ȸº¹°ú Àå¼ö¸¦ À§ÇÑ ÀúÀ§Çè °í¼öÀÍÀÇ ±æÀ» Á¦°øÇÔÀ¸·Î½á ȯÀÚÀÇ ±â´ë¸¦ À籸¼ºÇϰí ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº EVAR ½Ã¼úÀÇ Á¤È®¼º°ú Ä¡·á °á°ú¸¦ ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

Ç÷°ü³» µ¿¸Æ·ù ¼öº¹¼ú ºÐ¾ß´Â ½ºÅÙÆ® ÀÌ½ÄÆí µðÀÚÀÎ, ¿µ»ó ±â¼ú ¹× ½Ã¼úÀÇ ²÷ÀÓ¾ø´Â Çõ½Å¿¡ ÈûÀÔ¾î ºü¸£°Ô ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÃֽнºÅÙÆ® ±×·¡ÇÁÆ®´Â À¯¿¬¼º, ³»±¸¼º, ÀûÇÕ¼ºÀÌ ¶Ù¾î³ª¸ç, ±¸ºÒ±¸ºÒÇÑ Ç÷°üÀ̳ª °¢Áø Ç÷°üÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ È¯ÀÚ ÇØºÎÇÐÀû ±¸Á¶¿¡ ´ëÀÀÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ·¹ÀÏÇü ½ºÅÙÆ® ±×·¡ÇÁÆ®¿Í ºÐÁöÇü ½ºÅÙÆ® ±×·¡ÇÁÆ®ÀÇ µîÀåÀ¸·Î ½ÅÀ嵿¸Æ, Àå°ñµ¿¸Æ µî ÁÖ¿ä µ¿¸Æ ºÐÁö¸¦ Æ÷ÇÔÇϰųª ÀÌ¿¡ ±ÙÁ¢ÇÑ µ¿¸Æ·ù Ä¡·á°¡ °¡´ÉÇØÁ® ÀÌÀü¿¡´Â EVAR¿¡ ÀûÇÕÇÏÁö ¾Ê´Ù°í ¿©°ÜÁ³´ø ȯÀÚµµ Ä¡·áÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Ç»Àü À̹Ì¡ ¹× Ç÷°ü³» ÃÊÀ½ÆÄ(IVUS)¿Í °°Àº ½Ç½Ã°£ 3D ¿µ»ó À¯µµ ³»ºñ°ÔÀÌ¼Ç ½Ã½ºÅÛÀº ÀÌ½ÄÆí ¼³Ä¡ÀÇ Á¤È®µµ¸¦ ȹ±âÀûÀ¸·Î Çâ»ó½Ã۰í ÇÕº´Áõ°ú Á¶¿µÁ¦ÀÇ Çʿ伺À» °¨¼Ò½ÃÄ×½À´Ï´Ù. ·Îº¿ º¸Á¶ ¹× Ä«Å×ÅÍ ±â¹Ý Àü´Þ ½Ã½ºÅÛÀº ƯÈ÷ º¹ÀâÇÑ ´ëµ¿¸Æ ÇØºÎÇÐÀû ±¸Á¶¿¡¼­ Á¤È®µµ¿Í Á¶ÀÛÀÚ Á¦¾î¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. »ýüÈí¼ö¼º Àç·á ¹× ¾à¹° ¿ëÃ⼺ ½ºÅÙÆ® ±â¼ú Çõ½Åµµ ÀÌ½ÄÆí°úÀÇ ÅëÇÕÀ» °³¼±Çϰí ÀÌ½ÄÆí ´©Ãâ ¹× ÀÌ½ÄÆí À̵¿°ú °°Àº Àå±âÀûÀÎ À§ÇèÀ» ÁÙÀ̱â À§ÇØ ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù. ¿ø°Ý ÃßÀû °üÂû°ú ÇÕº´Áõ Á¶±â ¹ß°ßÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ¿þ¾î·¯ºí ±â¼ú°ú ¸ð¹ÙÀÏ Çコ Ç÷§ÆûÀÇ ¹ßÀüÀ¸·Î ½Ã¼ú ÈÄ ¸ð´ÏÅ͸µµµ ÇýÅÃÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº EVAR ½Ã¼úÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó Àû¿ë ¹üÀ§¸¦ ³ÐÇô Ç÷°ü ³» Ä¡·áÀÇ ÇѰ踦 ¶Ù¾î³Ñ°í ÀÖ½À´Ï´Ù.

¿Ö EVAR¿¡ ´ëÇÑ ¼ö¿ä°¡ Àα¸Åë°è¿Í Àü ¼¼°è Áö¿ª¿¡ °ÉÃÄ È®´ëµÇ°í Àִ°¡?

Ç÷°ü³» µ¿¸Æ·ù ¼öº¹¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â ÀÓ»óÀû, °æÁ¦Àû, Àα¸Åë°èÇÐÀû ¿äÀÎÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¿¬·É´ë, ȯÀÚ ÇÁ·ÎÇÊ, Áö¸®Àû Áö¿ªÀ» ÃÊ¿ùÇÏ¿© ºü¸£°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °í¼Òµæ ±¹°¡¿¡¼­´Â °í·ÉÈ­°¡ ÁÖ¿ä ¿øµ¿·ÂÀÌ µÇ°í ÀÖÀ¸¸ç, ƯÈ÷ 65¼¼ ÀÌ»ó ³²¼ºÀº º¹ºÎ ´ëµ¿¸Æ·ù(AAA)ÀÇ À§ÇèÀÌ ³ô½À´Ï´Ù. ÀÌµé ±¹°¡¿¡¼­´Â ÀÌ¹Ì È®¸³µÈ °ËÁø ÇÁ·Î±×·¥, °í±Þ ¿µ»ó Áø´Ü ´É·Â, Àü¹® Ç÷°ü ¼¾ÅÍ¿¡ ´ëÇÑ Á¢±Ù¼º µîÀÇ ÀÌÁ¡ÀÌ ÀÖ¾î ÆÄ¿­ÀÌ ¹ß»ýÇϱâ Àü¿¡ Á¶±â¿¡ Áø´ÜÇÏ°í ¼±ÅÃÀûÀ¸·Î EVARÀ» ½ÃÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹Ý¸é, ½ÅÈï±¹¿¡¼­´Â ´ç´¢º´, °íÇ÷¾Ð, Èí¿¬ µî ½ÉÇ÷°ü À§ÇèÀÎÀÚ°¡ ±ÞÁõÇϸ鼭 µ¿¸Æ·ùÀÇ ºÎ´ãÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó°¡ °³¼±µÇ°í Ç÷°ü ³» Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌµé ½ÃÀåÀº EVAR ±â¼ú¿¡ Å« ¼ºÀå ±âȸ°¡ µÉ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, EVARÀÇ Ã¤ÅÃÀº ÈÆ·ÃÀÇ ¹ßÀü, ½Ã¼úÀÇ Ç¥ÁØÈ­, °£¼ÒÈ­µÈ ½ºÅÙÆ® ÀÌ½Ä ½Ã½ºÅÛ µî¿¡ ÈûÀÔ¾î 3Â÷ ÀÇ·á ¼¾ÅͻӸ¸ ¾Æ´Ï¶ó Áö¿ª º´¿ø°ú µ¿³× º´¿ø±îÁö È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀڵ鵵 Ä¡·á °áÁ¤¿¡ ÀÖ¾î º¸´Ù Àû±ØÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ¸¹Àº ȯÀÚµéÀÌ È¸º¹ÀÌ ºü¸£°í ¼ö¼ú ÈÄ ÅëÁõÀÌ ÀûÀº ÃÖ¼Òħ½ÀÀû Ä¡·á¹ýÀ» ¼±È£Çϰí ÀÖ½À´Ï´Ù. °áÇÕÁ¶Á÷ ¼Õ»óÀ̳ª ¿Ü»ó¼º ´ëµ¿¸Æ ¼Õ»óÀÌ ÀÖ´Â ÀþÀº ȯÀÚ¿¡¼­ EVARÀÇ ÀûÀÀÁõ ¿Ü »ç¿ëÀÌ °ËÅäµÇ°í ÀÖÀ¸¸ç, À¯¸ÁÇÑ °á°ú¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ±º ÀÇ·áºÎÅÍ Àç³­ ´ëÀÀ ¹× À̵¿ ¼ö¼ú½Ç±îÁö, EVARÀÇ ´ÙÀç´Ù´ÉÇÔÀº ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡ ´ëÇÑ ÀûÀÀ¼ºÀ» ³ô¿© Àü ¼¼°è ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Ç÷°ü³» µ¿¸Æ·ù ¼öº¹¼ú ½ÃÀåÀÇ ¼ºÀå °¡¼ÓÈ­ ¿äÀÎÀº?

Ç÷°ü³» µ¿¸Æ·ù ¼öº¹¼ú ½ÃÀåÀÇ ¼ºÀåÀº ±â¼úÀû, ÀÓ»óÀû, °æÁ¦Àû, ±ÔÁ¦Àû ¿äÀÎÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇϰí ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ¿äÀεéÀº Á¾ÇÕÀûÀ¸·Î ÀÌ ºÐ¾ßÀÇ È®´ë¿Í ¼º¼÷À» °¡¸®Å°°í ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ ¼ºÀå ¿äÀÎ Áß Çϳª´Â ƯÈ÷ °í·ÉÈ­ »çȸ¿Í ½ÉÇ÷°ü À§Çè ¿äÀÎÀ» °¡Áø »ç¶÷µé »çÀÌ¿¡¼­ ´ëµ¿¸Æ·ù À¯º´·üÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â °ÍÀÔ´Ï´Ù. ÇÕº´Áõ ¹ß»ý·üÀÌ ³·°í, ȸº¹ ½Ã°£ÀÌ Âª°í, º´¿ø ÀÚ¿ø »ç¿ë·®ÀÌ Àû±â ¶§¹®¿¡ Á¡Á¡ ´õ ¸¹Àº ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ °³º¹ ¼ö¼úº¸´Ù EVARÀ» ¼±ÅÃÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ ¹× »óȯ Á¤Ã¥µµ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ´õ ¸¹Àº EVAR Àåºñ°¡ ´õ ³ÐÀº ÇØºÎÇÐÀû ÀûÀÀÁõÀ¸·Î ½ÂÀÎµÇ°í º¸Çè Àû¿ë °èȹ¿¡ ÅëÇյǰí ÀÖ½À´Ï´Ù. ¿Ü·¡ Ç÷°ü ¼ö¼ú ¼¾ÅÍ¿Í ÇÏÀ̺긮µå ¼ö¼ú½ÇÀÇ µîÀåÀ¸·Î º´¿øÀÌ ´ë±Ô¸ð ÀÎÇÁ¶ó ±¸Ãà ¾øÀ̵µ EVARÀ» µµÀÔÇÒ ¼ö ÀÖ´Â ¿©°ÇÀÌ Á¶¼ºµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µ¿¸Æ·ù Áõ»ó, À§Çè ¿äÀÎ, °ËÁø ±ÇÀå»çÇ׿¡ ´ëÇÑ ÀÇ»ç¿Í ȯÀÚ ¸ðµÎÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Á¶±â Áø´Ü°ú Àû½Ã °³ÀÔÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÇ·á±â±â Á¦Á¶¾÷üµéÀº Â÷¼¼´ë ÀÌ½Ä ¹× Àü´Þ ½Ã½ºÅÛÀ» °³¹ßÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, ½Ã¼úÀÇ º¹À⼺°ú Àå±âÀûÀÎ ÇÕº´ÁõÀ» ÁÙÀÏ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ ±â¼ú ÆÄÀÌÇÁ¶óÀÎÀ» ±¸ÃàÇϰí ÀÖ½À´Ï´Ù. ÀÓ»ó °¡À̵å¶óÀÎÀÌ ÃÖ¼Òħ½ÀÀû ¼Ö·ç¼ÇÀ» Áö¼ÓÀûÀ¸·Î ÁöÁöÇϰí Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÌ ¿¹¹æÀû Ä¡·á·Î ÀüȯÇÔ¿¡ µû¶ó, EVARÀº ¼º¼÷ ½ÃÀå°ú ½ÅÈï ½ÃÀå ¸ðµÎ¿¡¼­ Áö¼ÓÀûÀÌ°í ³ôÀº ¼ºÀå¼¼¸¦ À¯ÁöÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

ºÎ¹®

ÀûÀÀÁõ(º¹ºÎ ´ëµ¿¸Æ·ù, ÈäºÎ ´ëµ¿¸Æ·ù, ±âŸ ÀûÀÀÁõ), Á¦Ç°(°æÇÇÀû EVAR, õ°øÇü EVAR, ´ëµ¿¸Æ ½ºÅÙÆ® ¹× TAA ±×·¡ÇÁÆ®, ±âŸ Á¦Ç°)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 36°³»ç)

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× »ê¾÷º° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Endovascular Aneurysm Repair Market to Reach US$3.0 Billion by 2030

The global market for Endovascular Aneurysm Repair estimated at US$2.5 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 3.3% over the analysis period 2024-2030. Abdominal Aortic Aneurysm, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Thoracic Aortic Aneurysm segment is estimated at 3.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$677.6 Million While China is Forecast to Grow at 6.1% CAGR

The Endovascular Aneurysm Repair market in the U.S. is estimated at US$677.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$596.8 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Endovascular Aneurysm Repair Market - Key Trends & Drivers Summarized

Why Is Endovascular Aneurysm Repair Redefining Aneurysm Treatment in Vascular Medicine?

Endovascular Aneurysm Repair (EVAR) has revolutionized the management of abdominal and thoracic aortic aneurysms by providing a minimally invasive alternative to traditional open surgical repair. This technique involves inserting a stent graft through a small incision in the groin and navigating it via the femoral artery to the site of the aneurysm, where it is deployed to reinforce the weakened vessel wall and prevent rupture. EVAR offers numerous benefits over open surgery, including reduced blood loss, lower perioperative morbidity, shorter hospital stays, and faster recovery times. It is especially advantageous for elderly patients or those with comorbidities who may not tolerate major surgery. The rising global incidence of aortic aneurysms-driven by aging populations, hypertension, smoking, and atherosclerosis-has significantly increased the clinical need for safer, more efficient interventions like EVAR. As vascular imaging and stent-graft design continue to improve, EVAR has become the first-line treatment for many patients with suitable anatomy. Additionally, widespread screening programs and improved diagnostic imaging have led to earlier detection of asymptomatic aneurysms, expanding the potential candidate pool for EVAR procedures. As a result, EVAR is not only transforming how aneurysms are treated but also reshaping patient expectations by offering a lower-risk, high-reward path to recovery and longevity.

How Are Technological Innovations Enhancing the Precision and Outcomes of EVAR Procedures?

The field of endovascular aneurysm repair is advancing rapidly, fueled by continual innovations in stent graft design, imaging technologies, and procedural techniques. Modern stent grafts are now designed with greater flexibility, durability, and conformability to accommodate a wider range of patient anatomies, including those with tortuous or angulated vessels. The advent of fenestrated and branched stent grafts has made it possible to treat aneurysms that involve or are close to major arterial branches such as the renal and iliac arteries-cases that were previously deemed unsuitable for EVAR. Real-time 3D image-guided navigation systems, such as fusion imaging and intravascular ultrasound (IVUS), have dramatically improved the accuracy of graft placement, reducing complications and the need for contrast agents. Robotic-assisted and catheter-based delivery systems are enhancing precision and operator control, particularly in complex aortic anatomies. Innovations in bioresorbable materials and drug-eluting stents are also being explored to improve graft integration and reduce long-term risks such as endoleaks or graft migration. Post-procedural monitoring has benefited from advancements in wearable technology and mobile health platforms, which allow for remote follow-up and early detection of complications. Collectively, these innovations are not only improving the safety and efficacy of EVAR procedures but also expanding their applicability, pushing the boundaries of what can be achieved through endovascular intervention.

Why Is the Demand for EVAR Expanding Across Demographics and Global Regions?

The demand for endovascular aneurysm repair is expanding rapidly across age groups, patient profiles, and geographic regions due to a combination of clinical, economic, and demographic factors. In high-income countries, the aging population is a key driver, with men over 65 being particularly at risk for abdominal aortic aneurysms (AAA). These nations also benefit from established screening programs, advanced imaging capabilities, and access to specialized vascular centers, enabling early diagnosis and elective EVAR before rupture occurs. In contrast, emerging economies are seeing a surge in cardiovascular risk factors-including diabetes, hypertension, and smoking-contributing to a growing aneurysm burden. As healthcare infrastructure improves and access to endovascular procedures increases, these markets represent significant growth opportunities for EVAR technologies. Moreover, the adoption of EVAR is extending beyond tertiary care centers to regional and community hospitals, supported by advancements in training, procedural standardization, and simplified stent-graft systems. Patients are also playing a more active role in treatment decisions, with many favoring minimally invasive options that allow for quicker recovery and less postoperative pain. In younger patients with connective tissue disorders or traumatic aortic injuries, off-label use of EVAR is being explored with promising outcomes. From military medicine to disaster response and mobile surgical units, the versatility of EVAR makes it highly adaptable across diverse healthcare environments, further driving global demand.

What Factors Are Fueling the Accelerated Growth of the Endovascular Aneurysm Repair Market?

The growth in the endovascular aneurysm repair market is driven by a convergence of technological, clinical, economic, and regulatory factors that collectively point to an expanding and maturing field. One of the most significant growth drivers is the increasing prevalence of aortic aneurysms, particularly in aging populations and among individuals with cardiovascular risk factors. Healthcare providers are increasingly opting for EVAR over open surgery due to its lower complication rates, shorter recovery time, and reduced hospital resource utilization-factors that align well with value-based healthcare models and cost-containment initiatives. Regulatory approvals and reimbursement policies are also playing a crucial role, with more EVAR devices receiving clearance for broader anatomical indications and being included in insurance coverage plans. The rise of outpatient vascular surgery centers and hybrid operating rooms has made it more feasible for hospitals to adopt EVAR without major infrastructure overhauls. Additionally, increased awareness among both physicians and patients regarding aneurysm symptoms, risk factors, and screening recommendations is driving earlier diagnosis and timely intervention. Medical device companies are investing heavily in R&D to develop next-generation grafts and delivery systems, creating a pipeline of innovations that promise to reduce procedural complexity and long-term complications. As clinical guidelines continue to favor minimally invasive solutions and global healthcare systems pivot toward proactive, preventative care, EVAR is poised for sustained, high-growth momentum across both mature and emerging markets.

SCOPE OF STUDY:

The report analyzes the Endovascular Aneurysm Repair market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Other Indications); Product (Percutaneous EVAR, Fenestrated EVAR, Aortic Stents & TAA Graft, Other Products)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â